ZENITHDRUG.NS,0P0001SEP2,150400

ZENITHDRUG · General/Diversified · NSE

₹78

Current Market Price

Data Limited

Fair Value (DCF)

₹45

Margin of Safety

-42.8%

Updated 6h ago

DCF Sensitivity →

YieldIQ Score

37/100

Piotroski F-Score

2/9

Economic Moat

Narrow

Confidence

ROE

—

Debt/Equity

0.00

WACC

11.1%

Market Cap

₹135 Cr

Quality & Valuation

Neutral model outputs — no recommendations.

ROCE

—

Return on capital employed

EV / EBITDA

—

Enterprise multiple

Debt / EBITDA

—

Leverage vs earnings

Interest Coverage

—

EBIT covers interest

Current Ratio

—

Short-term liquidity

Asset Turnover

0.83×

Revenue per ₹ of assets

Revenue CAGR (3Y)

13.3%

3-year revenue growth

Revenue CAGR (5Y)

—

5-year revenue growth

DCF Scenario Analysis

vs CMP ₹78.45

Bear case

₹40.04

MoS -95.9%

Base case

₹44.84

MoS -75.0%

Bull case

₹63.08

MoS -24.4%

Ratio Trends

Historical ratio trends for ZENITHDRUG are being prepared. Once ready, this section will show multi-year trajectories of ROE, ROCE, margins, leverage, and valuation multiples.

Historical Financials

Historical financials for ZENITHDRUG are being prepared. Check back shortly for a 5-year view of revenue, earnings, cash flow, and balance-sheet trends.

Peer Comparison

Peers not yet ranked for ZENITHDRUG. Comparable companies and side-by-side valuation will appear here once the peer set is established.

Dividend History

No dividend events recorded for ZENITHDRUG in the last 10 years.

Reverse DCF

Market-implied growth

What FCF growth is priced in →

Risk Analysis

Recent activity

BSE filings + news for ZENITHDRUG →

Compare

Run Full Interactive Analysis

Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.

Analyse ZENITHDRUGNow →

Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.